BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 8401094)

  • 21. A comparison of medical and surgical termination of pregnancy: choice, emotional impact and satisfaction with care.
    Slade P; Heke S; Fletcher J; Stewart P
    Br J Obstet Gynaecol; 1998 Dec; 105(12):1288-95. PubMed ID: 9883920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
    Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.
    Winikoff B; Sivin I; Coyaji KJ; Cabezas E; Xiao B; Gu S; Du MK; Krishna UR; Eschen A; Ellertson C
    Am J Obstet Gynecol; 1997 Feb; 176(2):431-7. PubMed ID: 9065194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy.
    Thong KJ; Baird DT
    Contraception; 1992 Jul; 46(1):11-7. PubMed ID: 1424619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience and acceptability of medical abortion with mifepristone and misoprostol among U.S. women.
    Beckman LJ; Harvey SM
    Womens Health Issues; 1997; 7(4):253-62. PubMed ID: 9283280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in the concentration of alpha-fetoprotein and placental hormones following two methods of medical abortion in early pregnancy.
    Thong KJ; Norman JE; Baird DT
    Br J Obstet Gynaecol; 1993 Dec; 100(12):1111-4. PubMed ID: 7507707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical termination of early pregnancy: the Swedish experience.
    Bygdeman M; Danielsson KG; Marions L
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):195-6, 204. PubMed ID: 10846338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical abortion in Britain.
    Baird DT
    Br J Obstet Gynaecol; 1994 May; 101(5):367-8. PubMed ID: 8018604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptability of a nonsurgical method to terminate very early pregnancy in comparison to vacuum aspiration.
    Rosén AS; Nystedt L; Bygdeman M; Lundström V
    Contraception; 1979 Feb; 19(2):107-17. PubMed ID: 428228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is misoprostol the drug of choice for induced cervical ripening in early pregnancy termination?
    Platz-Christensen JJ; Nielsen S; Hamberger L
    Acta Obstet Gynecol Scand; 1995 Nov; 74(10):809-12. PubMed ID: 8533565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral misoprostol versus vaginal gemeprost for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestation.
    Ngai SW; Yeung KC; Lao T; Ho PC
    Contraception; 1995 Jun; 51(6):347-50. PubMed ID: 7554974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate and misoprostol for early abortion: a multicenter trial. Acceptability.
    Creinin MD; Burke AE
    Contraception; 1996 Jul; 54(1):19-22. PubMed ID: 8804803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conditions for choosing between drug-induced and surgical abortions.
    Bachelot A; Cludy L; Spira A
    Contraception; 1992 Jun; 45(6):547-59. PubMed ID: 1617964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of vaginal misoprostol and gemeprost as pre-treatment in first trimester pregnancy interruption.
    Henry AM; Haukkamaa M
    Br J Obstet Gynaecol; 1999 Jun; 106(6):540-3. PubMed ID: 10426610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiprogestin drugs: research and clinical use in Sweden.
    Bygdeman M; Swahn ML
    Law Med Health Care; 1992; 20(3):157-60. PubMed ID: 1434756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).
    Rodger MW; Baird DT
    Contraception; 1989 Oct; 40(4):439-47. PubMed ID: 2582769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mifepristone or vacuum aspiration in termination of early pregnancy.
    Legarth J; Peen UB; Michelsen JW
    Eur J Obstet Gynecol Reprod Biol; 1991 Sep; 41(2):91-6. PubMed ID: 1936497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation.
    Ashok PW; Kidd A; Flett GM; Fitzmaurice A; Graham W; Templeton A
    Hum Reprod; 2002 Jan; 17(1):92-8. PubMed ID: 11756368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.